BATF2 and cancer: Low Batf2 expression, in patients with colorectal cancer [74], hepatocellular carcinoma (HCC) [75] or oral tongue squamous cell carcinoma [76] do have significant increased mortality when compared to cancer patients with high Batf2 expression and overexpression of Batf2 [5] promotes growth inhibition and apoptosis in cancer cells, but not in normal cells.